Achieve Life Sciences Stock Price To Earnings To Growth
ACHV Stock | USD 4.41 0.08 1.78% |
Achieve Life Sciences fundamentals help investors to digest information that contributes to Achieve Life's financial success or failures. It also enables traders to predict the movement of Achieve Stock. The fundamental analysis module provides a way to measure Achieve Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achieve Life stock.
Achieve | Price To Earnings To Growth |
Achieve Life Sciences Company Price To Earnings To Growth Analysis
Achieve Life's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Achieve Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Achieve Life is extremely important. It helps to project a fair market value of Achieve Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Achieve Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Achieve Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Achieve Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Achieve Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Achieve Life Sciences has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
All Next | Launch Module |
Achieve Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Achieve Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Achieve Life's managers, analysts, and investors.Environmental | Governance | Social |
Achieve Fundamentals
Return On Equity | -1.86 | ||||
Return On Asset | -0.54 | ||||
Current Valuation | 121.34 M | ||||
Shares Outstanding | 34.39 M | ||||
Shares Owned By Insiders | 9.72 % | ||||
Shares Owned By Institutions | 59.64 % | ||||
Number Of Shares Shorted | 3 M | ||||
Price To Earning | (0.03) X | ||||
Price To Book | 4.92 X | ||||
EBITDA | (26.73 M) | ||||
Net Income | (29.82 M) | ||||
Cash And Equivalents | 29.38 M | ||||
Cash Per Share | 3.03 X | ||||
Total Debt | 16.73 M | ||||
Debt To Equity | 1.18 % | ||||
Current Ratio | 5.81 X | ||||
Book Value Per Share | 0.91 X | ||||
Cash Flow From Operations | (24.48 M) | ||||
Short Ratio | 26.81 X | ||||
Earnings Per Share | (1.12) X | ||||
Target Price | 16.44 | ||||
Number Of Employees | 22 | ||||
Beta | 1.58 | ||||
Market Capitalization | 154.41 M | ||||
Total Asset | 19.37 M | ||||
Retained Earnings | (165.75 M) | ||||
Working Capital | (3.83 M) | ||||
Current Asset | 22.54 M | ||||
Current Liabilities | 9.1 M | ||||
Net Asset | 19.37 M |
About Achieve Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achieve Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achieve Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achieve Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.